FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

413468006: Product containing precisely agalsidase beta 5 milligram/1 vial powder for conventional release solution for injection (clinical drug)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3689389016 Agalsidase beta 5 mg powder for solution for injection vial en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3689390013 Product containing precisely agalsidase beta 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Agalsidase beta 5 mg powder for solution for injection vial est un(e) (attribut) Agalsidase beta only product in parenteral dose form true Inferred relationship Some
Agalsidase beta 5 mg powder for solution for injection vial est un(e) (attribut) agalsidase bêta false Inferred relationship Some
Agalsidase beta 5 mg powder for solution for injection vial a pour principe actif (attribut) Alpha-galactosidase false Inferred relationship Some
Agalsidase beta 5 mg powder for solution for injection vial a pour principe actif (attribut) agent biologique false Inferred relationship Some
Agalsidase beta 5 mg powder for solution for injection vial a une forme pharmaceutique (attribut) Injection false Inferred relationship Some
Agalsidase beta 5 mg powder for solution for injection vial a pour principe actif (attribut) Agalsidase beta (substance) false Inferred relationship Some
Agalsidase beta 5 mg powder for solution for injection vial est un(e) (attribut) Product manufactured as parenteral dose form (product) false Inferred relationship Some
Agalsidase beta 5 mg powder for solution for injection vial a une forme pharmaceutique (attribut) Powder for solution for injection true Inferred relationship Some
Agalsidase beta 5 mg powder for solution for injection vial Has basis of strength substance (attribute) Agalsidase beta (substance) true Inferred relationship Some 1
Agalsidase beta 5 mg powder for solution for injection vial Has presentation strength numerator unit milligram (qualifier value) true Inferred relationship Some 1
Agalsidase beta 5 mg powder for solution for injection vial Has unit of presentation Vial (unit of presentation) true Inferred relationship Some
Agalsidase beta 5 mg powder for solution for injection vial Has presentation strength denominator value un false Inferred relationship Some 1
Agalsidase beta 5 mg powder for solution for injection vial Has presentation strength numerator value (attribute) cinq false Inferred relationship Some 1
Agalsidase beta 5 mg powder for solution for injection vial Count of base of active ingredient un false Inferred relationship Some
Agalsidase beta 5 mg powder for solution for injection vial Has precise active ingredient Agalsidase beta (substance) true Inferred relationship Some 1
Agalsidase beta 5 mg powder for solution for injection vial Has presentation strength denominator unit (attribute) Vial (unit of presentation) true Inferred relationship Some 1

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

Canada English language reference set (foundation metadata concept)

Description inactivation indicator reference set

GB English

US English

Back to Start